RETRACTED: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19

Short impact summary

The article "Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19" has garnered significant attention since its retraction, highlighting the ongoing debates in the field of cardiovascular health and infectious diseases. With nearly 1,500 citations, the work has influenced numerous studies and discussions, despite its controversial standing marked by a retraction notice.

Full narrative

Originally published in the prestigious New England Journal of Medicine, this article by Mandeep R. Mehra and colleagues was ultimately retracted, catalyzing critical discourse among scholars and the broader medical community. The retraction signals the complexities and challenges surrounding research integrity, particularly in high-stakes areas such as COVID-19 and cardiovascular health, which have become increasingly prevalent in scientific discussions.

Despite its retraction, the paper has achieved substantial academic impact, as evidenced by its citation count of 1,495. This reflects ongoing engagement with its content and its role in shaping subsequent research in the field of cardiovascular disease related to COVID-19. Such engagement underscores the importance of rigorous methodological scrutiny and the dynamics of scientific discourse in emerging research areas.

The work also generated public interest, with mentions across various platforms, including five entries on Wikipedia, four threads on Reddit, and three posts on Bluesky. These discussions illustrate how the article resonates beyond academia, reflecting its societal relevance and contributing to the ongoing conversation about COVID-19's impact on cardiovascular health.

Notably, the research has fostered active debate and further inquiry, evidenced by the presence of four PubPeer threads. This scrutiny by the community emphasizes the necessity for transparency and critical evaluation in scientific research, particularly given the implications of the findings in public health strategies. Additionally, the retraction itself has served as a learning opportunity for researchers and institutions alike, promoting a culture of accountability and rigorous debate in the fields of medicine and public health.